(redirected from Initial Body Mass)
IBMInternational Business Machines Corporation
IBMInternational Business Management (college program)
IBMInternational Business and Marketing (various organizations)
IBMInclusion Body Myositis (inflammatory muscle disease)
IBMIntercontinental Ballistic Missile (also ICBM)
IBMIndian Bureau of Mines (India)
IBMIntegrated Business Management (Sales & Operations Planning)
IBMInternational Brotherhood of Magicians
IBMIntegrated Border Management
IBMImmersed Boundary Method (mathematics)
IBMIndividual-Based Modeling
IBMInjection Blow Moulding
IBMIzu-Bonin-Mariana (island arc)
IBMInternational Bank of Miami (Florida)
IBMInternational Business Machines
IBMIntelligent Battery Management
IBMInitial Body Mass
IBMIrritable Bowel Movement
IBMInternational Board Meeting (various organizations)
IBMI Buy Macintosh
IBMInstitut des Biosciences Marines (French; Canada)
IBMIch Bin Müde (German: I Am Tired)
IBMIntegrated Business Module
IBMIdeal Breeding Material
IBMIssue Based Module (various organizations)
IBMInclusion Body Myopathy
IBMItalian By Marriage
IBMInternational Baptist Missions
IBMIntensive Bowel Movement
IBMInternal Bench Mark (procurement)
IBMInspection by Modularization
References in periodicals archive ?
This similarity in initial body mass between the control and experimental groups allowed us to use the mean final mass to compare any change in body mass that might be due to ingestion of H.
The changes in initial body mass throughout the session (i.e., dehydration) were minimal and not significant, and similar in PEP (-0.30 [+ or -] 0.14%) and LP (-0.15 [+ or -] 0.10%) confirming that all subjects remained euhydrated.
The most striking finding was that people who had an initial body mass index (BMI) score of 18.5 kg/[m.sup.2] or less and experienced weight gains of 10% or less during the first 3 months of antiretroviral therapy were far more likely to die within the next 3 months than people who had comparable initial BMI scores but experienced greater weight gains.
Partial correlations between the plasma leptin levels and body weight 1st trimester leptin Initial body mass level index r (P values) r (P values) Initial BMI (kg/[m.sup.2]) 0.568 (0.007) Weight gain during -0.099 (0.451) pregnancy (kg) 0.012 (0.960) Weight at term (kg) 0.440 (0.046) 0.904 (0.001) BMI at term (kg/[m.sup.2]) 0.565 (0.008) 0.822 (0.001) Weight at 6 wk - 0.025 (0.962) 0.938 (0.001) postpartum (kg) Weight at 6 months 0.047 (0,953) 0896 (0.003) postpartum (kg) * Partial correlation coefficients adjusted for age, postpartum hypocaloric diet
Because initial body mass was used as a covariate (Pillai's Trace = 0.337; [F.sub.3,20] = 3.38; p = 0.038), body mass after oviposition estimates the somatic mass gained from adult molt to oviposition.
The amount of proteins consumed by the subjects during the first, second and third day of RBML period in relation to initial body mass was 0.67 [+ or -] 0.37 g x [kg.sup.-1], 0.52 [+ or -] 0.43 g x [kg.sup.-1] and 0.11 [+ or -] 0.17 g x [kg.sup.-1] and that of carbohydrates 2.66 [+ or -] 1.43 g x [kg.sup.-1], 2.09 [+ or -] 1.14 g x [kg.sup.-1] and 0.45 [+ or -] 0.40 g x [kg.sup.-1], respectively.
Using linear regression, cuticular permeability values (using Meeh's formula to calculate body surface area) were not significantly (P > 0.05) related to initial body mass for all three species.
The subjects' mortality hazard rate ratios were adjusted for age, sex, ethnicity, education, smoking, health status, health care utilization and initial body mass index.
A genetic predisposition to thinness, physical activity, older age, higher initial body mass index (BMI), and lower smoking rates are reported to be associated with lower weight gain following smoking cessation (Table).
In these analyses, each larva served as a replicate, and the factors were treatment and initial body mass. These analyses violated the assumption of independence of larvae within a replicate, but they revealed the effects of body size on larval fate, which could not be accommodated in conventional ANOVAs.
The report points out that losing small amounts of weight -- just 10 to 15 percent of initial body mass -- can provide significant health benefits.
Belviq/Belviq XR is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes).
Full browser ?